companydata.dkcompanydata.dk

PHARMA PRODUCTION ApS: Financial statements 2024

CVR: 66108813

Source: annual report 2024, Danish Business Authority

01/10/2023 – 30/09/2024

PHARMA PRODUCTION ApS (CVR 66108813) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 155,799 and a net result of DKK -20,470 compared with DKK 384,028 the year before. That is a decrease of 77.6% compared with the year before. Equity in the 2024 report amounted to DKK 16,564,784. The solvency ratio was 65.6%.

Gross Profit
DKK 155,799
Profit/Loss
DKK -20,470
Equity
DKK 16,564,784
Total Assets
DKK 25,243,135
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-156 t.-20 t.16.6 mio.0
2023-695 t.384 t.16.6 mio.1
2022-710 t.377 t.16.2 mio.1
2021-496 t.91 t.15.8 mio.1
2020-837 t.315 t.15.7 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

PHARMA PRODUCTION ApS: The 2023 annual report is outApr 3, 2024

PHARMA PRODUCTION ApS has published its annual report for 2023. Gross profit came to DKK 694,938, and the net result was DKK 384,028.

About PHARMA PRODUCTION ApS

PHARMA PRODUCTION ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 1980. The company is registered under the industry Bogføring og revision; skatterådgivning. The company was previously named MEDICAPHARMA ApS and MATERIALISTEN GRAVENSGADE 8, AALBORG ApS. The management consists of Finn Jørgen Jensen. The company is owned by Bispensgade Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 19,077 and a net result of DKK -95,659 compared with DKK -20,470 the year before. Equity in the 2025 report amounted to DKK 16,469,125.

Source: annual report 2025, Danish Business Authority